Literature DB >> 10593998

Presymptomatic testing for BRCA1 and BRCA2: how distressing are the pre-test weeks? Rotterdam/Leiden Genetics Working Group.

L N Lodder1, P G Frets, R W Trijsburg, E J Meijers-Heijboer, J G Klijn, H J Duivenvoorden, A Tibben, A Wagner, C A van der Meer, P Devilee, C J Cornelisse, M F Niermeijer.   

Abstract

Presymptomatic DNA testing for autosomal dominant hereditary breast/ovarian cancer (HBOC) became an option after the identification of the BRCA1 and BRCA2 genes in 1994-1995. Healthy female mutation carriers have a high lifetime risk for breast cancer (56-87%) or ovarian cancer (10-60%) and may opt for intensive breast and ovary surveillance or prophylactic surgery (mastectomy/oophorectomy). We studied general and cancer related distress in 85 healthy women with a 25% or 50% risk of being carrier of a BRCA1/BRCA2 gene mutation and 66 partners in the six to eight week period between genetic counselling/blood sampling and disclosure of the test result. Questionnaire and interview data are analysed. Associations are explored between levels of distress and (1) expected consequences of being identified as a mutation carrier, (2) personality traits, (3) sociodemographic variables, and (4) experiences related to HBOC. Mean pre-test anxiety and depression levels in women at risk of being a carrier and partners were similar to those of a normal Dutch population. In about 25% of those at risk of being a carrier and 10% of the partners, increased to high levels of general and cancer related distress were found. Increased levels of distress were reported by women who (1) anticipated an increase in problems after an unfavourable test outcome, (2) considered prophylactic mastectomy if found to be mutation carrier, (3) had an unoptimistic personality, (4) tended to suppress their emotions, (5) were younger than 40 years, and (6) were more familiar with the serious consequences of HBOC. Recently obtained awareness of the genetic nature of cancer in the family was not predictive of distress.The majority of the women and their partners experienced a relatively calm period before the disclosure of the test result and seemed to postpone distressing thoughts until the week of disclosure of the result. The low distress levels may partly be explained by the use of strategies to minimise the emotional impact of a possibly unfavourable test outcome. However, a minority reported feeling very distressed. Several factors were found to be predictive for increased distress levels.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10593998      PMCID: PMC1734277     

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  27 in total

1.  Presymptomatic DNA-testing for Huntington disease in The Netherlands.

Authors:  A Tibben; M Vegter-vd Vlis; M I Skraastad; I S Leeuwen-Cornelisse; P G Frets; J J vd Kamp; M F Niermeijer; G J von Ommen; R A Roos; H G Rooijmans
Journal:  Birth Defects Orig Artic Ser       Date:  1992

2.  The SCL-90 and the MMPI: a step in the validation of a new self-report scale.

Authors:  L R Derogatis; K Rickels; A F Rock
Journal:  Br J Psychiatry       Date:  1976-03       Impact factor: 9.319

3.  Emotional control and autonomic arousal in breast cancer patients.

Authors:  M Watson; K W Pettingale; S Greer
Journal:  J Psychosom Res       Date:  1984       Impact factor: 3.006

4.  Optimism, coping, and health: assessment and implications of generalized outcome expectancies.

Authors:  M F Scheier; C S Carver
Journal:  Health Psychol       Date:  1985       Impact factor: 4.267

5.  Anxiety and depression in patients with chest pain referred for exercise testing.

Authors:  K S Channer; M Papouchado; M A James; J R Rees
Journal:  Lancet       Date:  1985-10-12       Impact factor: 79.321

6.  Presymptomatic DNA-testing for Huntington disease: pretest attitudes and expectations of applicants and their partners in the Dutch program.

Authors:  A Tibben; P G Frets; J J van de Kamp; M F Niermeijer; M Vegter-van der Vlis; R A Roos; G J van Ommen; H J Duivenvoorden; F Verhage
Journal:  Am J Med Genet       Date:  1993-05-01

7.  Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Application to the NIMH treatment of Depression Collaborative Research Program dataset.

Authors:  R D Gibbons; D Hedeker; I Elkin; C Waternaux; H C Kraemer; J B Greenhouse; M T Shea; S D Imber; S M Sotsky; J T Watkins
Journal:  Arch Gen Psychiatry       Date:  1993-09

8.  The hospital anxiety and depression scale.

Authors:  A S Zigmond; R P Snaith
Journal:  Acta Psychiatr Scand       Date:  1983-06       Impact factor: 6.392

9.  Psychological distress and surveillance behaviors of women with a family history of breast cancer.

Authors:  K M Kash; J C Holland; M S Halper; D G Miller
Journal:  J Natl Cancer Inst       Date:  1992-01-01       Impact factor: 13.506

10.  Impact of Event Scale: a measure of subjective stress.

Authors:  M Horowitz; N Wilner; W Alvarez
Journal:  Psychosom Med       Date:  1979-05       Impact factor: 4.312

View more
  23 in total

1.  Uptake of BRCA1 genetic testing in adult sisters and daughters of known mutation carriers in Norway.

Authors:  Trine Levin Bodd; Jon Reichelt; Ketil Heimdal; Pal Moller
Journal:  J Genet Couns       Date:  2003-10       Impact factor: 2.537

2.  Predictive testing of eighteen year olds: counseling challenges.

Authors:  Clara L Gaff; Elly Lynch; Lesley Spencer
Journal:  J Genet Couns       Date:  2006-08       Impact factor: 2.537

3.  Identification of cognitive profiles among women considering BRCA1/2 testing through the utilisation of cluster analytic techniques.

Authors:  Pagona Roussi; Kerry A Sherman; Suzanne M Miller; Karen Hurley; Mary B Daly; Andrew Godwin; Joanne S Buzaglo; Kuang-Yi Wen
Journal:  Psychol Health       Date:  2011-07-14

4.  Psychological factors associated with emotional responses to receiving genetic risk information.

Authors:  Paul Bennett; Clare Wilkinson; Jim Turner; Kate Brain; Rhiannon Tudor Edwards; Gethin Griffith; Barbara France; Jonathon Gray
Journal:  J Genet Couns       Date:  2008-02-08       Impact factor: 2.537

Review 5.  Cancers related to genetic mutations: important psychosocial issues for Canadian family physicians.

Authors:  Tara E Power; John Robinson
Journal:  Can Fam Physician       Date:  2006-11       Impact factor: 3.275

6.  Health behaviors and psychological distress in women initiating BRCA1/2 genetic testing: comparison with control population.

Authors:  Michel Dorval; Karine Bouchard; Elizabeth Maunsell; Marie Plante; Jocelyne Chiquette; Stéphanie Camden; Michel J Dugas; Jacques Simard
Journal:  J Genet Couns       Date:  2008-05-15       Impact factor: 2.537

7.  Experiences and decisions that motivate women at increased risk of breast cancer to participate in an experimental screening program.

Authors:  Michelle Proulx; Marie-Dominique Beaulieu; Christine Loignon; Marie-Hélène Mayrand; Christine Maugard; Nathalie Bellavance; Diane Provencher
Journal:  J Genet Couns       Date:  2009-02-14       Impact factor: 2.537

8.  A Counselling Model for BRCA1/2 Genetic Susceptibility Testing.

Authors:  Iris van Oostrom; Aad Tibben
Journal:  Hered Cancer Clin Pract       Date:  2004-02-15       Impact factor: 2.857

9.  Exploration of Male Attitudes on Partnerships and Sexuality with Female BRCA1/2 Mutation Carriers.

Authors:  Caitlin Mauer; Sara Spencer; Jeffery Dungan; Karen Hurley
Journal:  J Genet Couns       Date:  2015-08-08       Impact factor: 2.537

10.  Changes in psychological distress after cancer genetic counselling: a comparison of affected and unaffected women.

Authors:  A Bish; S Sutton; C Jacobs; S Levene; A Ramirez; S Hodgson
Journal:  Br J Cancer       Date:  2002-01-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.